IGF-1 is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-01-06. Numbers and descriptions here follow the published literature rather than marketing material.
Analytical characterization of AOD-9604 typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) to assess purity and identity. Mass spectrometry provides confirmation of molecular mass, while amino acid analysis can verify composition. These methods are standard for peptide research chemicals. Because the peptide lacks a distinct chromophore, detection often relies on ultraviolet absorbance at 214 nm or mass spectrometric response. Laboratories may also use capillary electrophoresis for separation. For example, size-exclusion chromatography can detect aggregates.
Stability of AOD-9604 depends on storage conditions. Lyophilized powder is generally more stable than reconstituted solution. Recommended storage is typically at -20°C or lower, protected from light and moisture. Repeated freeze-thaw cycles can cause aggregation or degradation. In solution, the peptide may be susceptible to hydrolysis or oxidation, so aliquoting and cold storage are common practices. Researchers often add stabilizers such as mannitol or trehalose during lyophilization to improve shelf life.
Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.
AOD-9604 is a synthetic peptide whose structure corresponds to a C-terminal segment of human growth hormone. It is often described as hGH fragment 176-191, a 16-amino-acid sequence. The peptide was designed to isolate a region of hGH associated with fat metabolism while avoiding the full hormone's growth-promoting actions. Laboratory and commercial materials typically present it as a lyophilized powder for research use. Its identity is defined by amino acid sequence, not by a single brand.
The fragment includes residues that can form an internal disulfide bond between two cysteine positions. This structural feature can influence how the peptide folds and how stable it is in solution. AOD-9604 differs from full-length hGH in size and receptor interactions; it does not contain the entire growth hormone sequence. Published descriptions sometimes use slightly different residue numbering, so sequence information should be checked against primary sources. The molecule is small compared with intact hGH, which affects analytical detection and purification approaches.
| Property | Value | Notes |
|---|---|---|
| Appearance | White to off-white powder | Lyophilized form |
| Solubility | Soluble in water | Also soluble in aqueous buffers |
| Storage temperature | -20°C or below | Protect from light and moisture |
| Analytical method | RP-HPLC | Purity and identity assessment |
| Mass confirmation | Mass spectrometry | Verifies molecular mass |
AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.
Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.
Clinical development of AOD-9604 included trials in people with obesity. Reports from early-phase and mid-phase studies described modest or inconsistent changes in body weight. A phase IIb program did not meet its primary endpoint, and the compound was not approved for medical use. Differences in formulation, delivery route, and participant characteristics may explain some of the variation. Later investigations explored whether the peptide might have effects in other tissues, including cartilage.
Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.
AOD-9604 is typically supplied as a lyophilized white to off-white powder. In this form, it is relatively stable when kept cool, dry, and protected from light. Common storage recommendations place it at −20 °C or below for long-term retention. Reconstituted solutions are less stable and are often kept at 2–8 °C for short periods. Freeze-thaw cycles should be minimized because they can promote aggregation or loss of peptide content. Vials are usually sealed under inert gas to reduce oxidation.
Identity and purity are commonly checked with reversed-phase high-performance liquid chromatography and mass spectrometry. RP-HPLC separates the peptide from related impurities and can estimate purity by peak area. Mass spectrometry confirms molecular mass and helps detect sequence variants or truncations. Some laboratories use amino acid analysis or peptide mapping for additional characterization. No single method proves biological activity; these techniques establish chemical identity and purity only. They also require suitable reference standards for confident comparison.
Commercial AOD-9604 may vary in purity, counterion content, and residual moisture. Certificates of analysis often report HPLC purity, mass confirmation, and appearance, but testing methods differ between suppliers. Independent verification is sometimes used because labeled content may not match actual peptide amount. Stability under different pH and temperature conditions is not fully standardized across studies. Researchers generally treat lyophilized material as the reference form for weighing and reconstitution. Moisture content can affect accurate mass measurement.
=== Sabatier reaction === Methane synthesized by Sabatier reaction is largely depleted in CH2D2 and slightly depleted in 13CH3D relative to the equilibrium state. It has been proposed that quantum tunneling effects result in the low
== History == During his visit to Paris, France, in 2005, Muhammad Yunus, the founder of Grameen Bank was invited by Franck Riboud, the chief executive officer of Groupe Danone (known as Dannon in the US). On 12 October 2005, they met in La Fontaine Gaillon, a Parisian restaurant. There Yunus proposed to form a joint venture between Grameen and Danone with the objective of supplying nutritious food to poor children of Bangladesh. As proposed by Muhammad Yunus, Franck Riboud agreed to participate in the project to be styled a social business. Accordingly, the Grameen Group and Groupe Danone entered into an agreement to form a company called Grameen Danone Foods – a social business in Bangladesh. The objective was to bring daily healthy nutrition to low income nutritionally deprived populations in Bangladesh and alleviate poverty through the implementation of a community based business model, where no profit will be appropriated by the investing partners. The launch of Grameen Danone received considerable attention and was attended by celebrities including French soccer player Zinedine Zidane of France. Grameen Danone was led by Corinne Bazina from 2010 to 2014, Eric Ipavec from 2014 to 2016, Valérie Mazon from 2017 to 2018, and Dipesh Nag since 2020.
=== Linde and CCMP Capital (2006-2014) === Linde AG purchased BOC in 2006 for €12.4 billion, selling Edwards to CCMP Capital and its Asian fund in 2007 for US$901 million. Edwards was renamed Edwards Group Ltd, and then Edwards Group plc. A new, Cayman Island-based holding company called Edwards Group Ltd was listed on NASDAQ in 2012 via ADS under the ticker symbol EVAC, with a US$100 million IPO. It was delisted in 2014 when Atlas Copco purchased the operating subsidiary Edwards Ltd for £1 billion.
Sources: en.wikipedia.org
According to the 2021 Romanian census, Romania's population was 19,053,815. Like other countries in the region, its population is expected to decline gradually as a result of sub-replacement fertility rates and negative net migration rate. According to the 2021 Romanian census, Romanians made up 89.33% of the population, Hungarians 6.05% and the Roma 3.44% of the population, but many ethnicities are not recorded, as they do not have ID cards. International sources give higher figures for Roma than the official census. According to the Council of Europe, the Roma make up 8.32% of the population; this figure is difficult to verify due to the mobility of Roma and the reluctance of some of them to disclose their ethnicity. Hungarians constitute a majority in the counties of Harghita and Covasna. Other minorities include Ukrainians, Germans, Turks, Lipovans, Aromanians, Tatars, and Serbs. In 1930, there were 745,421 Germans living in Romania, but only about 36,000 remained in the country to this day. As of 2009, there were also approximately 133,000 immigrants living in Romania, primarily from Moldova and China. The total fertility rate (TFR) in 2018 was estimated at 1.36 children born per woman, which is below the replacement rate of 2.1, and one of the lowest in the world; it remains considerably below the high of 5.82 children born per woman in 1912. In 2014, 31.2% of births were to unmarried women.
Turkey has 208 higher education institutions. These include 129 public universities, 11 technical universities, one institute of technology, and two fine arts universities. In addition, there are 75 private foundation universities and four private institutions that offer only two-year degrees. Specialized institutions include the National Defence University and the Police Academy. The higher education system is regulated by the Council of Higher Education.
Organomagnesium compounds are widespread in organic chemistry. They are commonly found as Grignard reagents, formed by reaction of magnesium with haloalkanes or aryl halides in diethyl ether. Examples of Grignard reagents are phenylmagnesium bromide and ethylmagnesium bromide. The Grignard reagents function as a common nucleophile, attacking the electrophilic group such as the carbon atom that is present within the polar bond of a carbonyl group. A prominent organomagnesium reagent beyond Grignard reagents is magnesium anthracene or magnesocene, which is used as a source of highly active magnesium. First prepared in 1954 by independent groups, one led by Ernst Otto Fischer, the other by Albert Wilkinson, magnesocene is a white to off-yellow pyrophoric powder that violently hydrolyses in water. The related butadiene-magnesium adduct serves as a source for the butadiene dianion. Complexes of dimagnesium(I) have been observed.
Sources: en.wikipedia.org
Reversed-phase HPLC is used to assess purity, and mass spectrometry confirms molecular mass. Amino acid analysis can verify composition. These methods are standard for peptide characterization.
Lyophilized powder should be stored at -20°C or lower, protected from light and moisture. Reconstituted solutions are less stable and should be aliquoted to avoid freeze-thaw cycles. Always follow supplier instructions.
Variability in purity, counterion content, and residual solvents is possible. Independent testing and certificates of analysis help verify quality. Microbial contamination can occur if handling is not sterile.
It is a synthetic peptide based on a C-terminal fragment of human growth hormone. It is commonly referred to as hGH fragment 176-191 and is studied for metabolic effects rather than growth effects.